Delpor, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160) (NCT05304364) | Delpor, Inc. | 2022-03-22 |
| Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant (NCT04418466) | Delpor, Inc. | 2021-04-01 |
Track Delpor, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.